PFO
AGN

Pathstone Family Office’s Allergan plc AGN Stock Holding History

Pathstone Family Office’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-2,886
Closed -$511K – 1050
2020
Q1 		$511K Buy
2,886
+112
+4% +$21.1K 0.07% 102
2019
Q4 		$5.3M Hold
2,774
– – 0.06% 99
2019
Q3 		$467K Hold
2,774
– – 0.06% 95
2019
Q2 		$464K Hold
2,774
– – 0.05% 136
2019
Q1 		$406K Buy
+2,774
New +$402K 0.05% 125
2018
Q2 		– Sell
-8
Closed -$1K – 365
2018
Q1 		$1K Hold
8
– – ﹤0.01% 364
2017
Q4 		$1K Buy
+8
New +$1.44K ﹤0.01% 155
2017
Q3 		– Sell
-366
Closed -$89K – 365
2017
Q2 		$89K Buy
366
+355
+3,227% +$83.4K 0.04% 158
2017
Q1 		$3K Buy
+11
New +$2.56K ﹤0.01% 361
2016
Q1 		– Sell
-20
Closed -$6K – 190
2015
Q4 		$6K Sell
20
-24
-55% -$7.14K 0.03% 68
2015
Q3 		$12K Sell
44
-28
-39% -$8.6K 0.03% 79
2015
Q2 		$22K Buy
72
+36
+100% +$10.7K 0.04% 54
2015
Q1 		$11K Buy
+36
New +$10.3K 0.02% 84

Other funds holding AGN

AJ
Ashburton (Jersey) St Helier, Jersey $227M AUM
C
Cerebellum San Francisco, California $21.5M AUM
B
Barings Charlotte, North Carolina $6.19B AUM 16.5% 1-Year Est. Return
JJ
JDC-JSC New York $20.8M AUM 30.94% 1-Year Est. Return
VFA
Valeo Financial Advisors Carmel, Indiana $4.74B AUM 27.69% 1-Year Est. Return
OPS
Orion Portfolio Solutions Omaha, Nebraska $10.2B AUM 6.73% 1-Year Est. Return

Pathstone Family Office's AGN Position: Q2 2020 in Review

Pathstone Family Office sold out of Allergan plc (AGN) in Q2 2020, closing a stake of 2,886 shares — an estimated $511K sold.

Pathstone Family Office first reported a position in AGN in Q1 2015 and held it in 13 quarters. The position peaked at $5.3M in Q4 2019. 7 funds tracked by Wall St. Rank hold AGN as of Q2 2020.

  • Pathstone Family Office reported no remaining Allergan plc position as of Q2 2020 after selling out during the quarter.
  • Pathstone Family Office sold 2,886 Allergan plc shares in Q2 2020, an estimated $511K.
  • Pathstone Family Office first reported a position in Allergan plc in Q1 2015 and held it in 13 quarters.
  • Pathstone Family Office's Allergan plc position peaked at $5.3M in Q4 2019.
  • 7 funds tracked by Wall St. Rank held Allergan plc as of Q2 2020.

Based on Pathstone Family Office's 13F filing for Q2 2020, filed 14 Aug 2020.